Einhorn Andrew J.

CIK 00015606854 companiesCEDAR KNOLLS, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001560685

Recent Transactions

24 trades

Tax Payment
RVL Pharmaceuticals plc
Ordinary Shares
2022-01-24$1.13/sh−9,607→ 141,473 total
Award
RVL Pharmaceuticals plc
Share Option (Right to Buy)
2021-11-04+249,814→ 249,814 total
Tax Payment
RVL Pharmaceuticals plc
Ordinary Shares
2021-05-18$3.12/sh−6,467→ 151,080 total
Tax Payment
RVL Pharmaceuticals plc
Ordinary Shares
2021-01-24$4.46/sh−9,668→ 157,547 total
Award
RVL Pharmaceuticals plc
Performance-Based Restricted Stock Units
2020-05-18+71,550→ 71,550 total
Award
RVL Pharmaceuticals plc
Ordinary Shares
2020-05-18+71,550→ 167,215 total
Tax Payment
RVL Pharmaceuticals plc
Ordinary Shares
2020-01-28$7.00/sh−9,184→ 95,665 total
Award
RVL Pharmaceuticals plc
Ordinary Shares
2019-01-24+104,849→ 104,849 total
Exercise of In-Money
PDS Biotechnology Corp$PDSB
Warrants (right To Purchase)
2017-03-01−1,567→ 0 total
Exercise of In-Money
PDS Biotechnology Corp$PDSB
Common Stock
2017-03-01$2.39/sh+1,567→ 43,223 total
Award
PDS Biotechnology Corp$PDSB
Stock Option (Right to Purchase)
2016-02-16+50,000→ 50,000 total
Conversion
PDS Biotechnology Corp$PDSB
Common Stock
2015-10-06+4,747→ 15,190 total
Conversion
PDS Biotechnology Corp$PDSB
Series C Convertible Preferred Stock
2015-10-06−6,494→ 0 total
Conversion
PDS Biotechnology Corp$PDSB
Series C-1 Convertible Preferred Stock
2015-10-06−32,956→ 0 total
Conversion
PDS Biotechnology Corp$PDSB
Common Stock
2015-10-06+24,089→ 39,279 total
Other
PDS Biotechnology Corp$PDSB
Common Stock
2015-10-06$7.75/sh+1,651→ 83,592 total
Conversion
PDS Biotechnology Corp$PDSB
Series C-1 Convertible Preferred Stock
2015-10-06−21,506→ 0 total
Conversion
PDS Biotechnology Corp$PDSB
Series C-2 Convertible Preferred Stock
2015-10-06−29,032→ 0 total
Other
PDS Biotechnology Corp$PDSB
Common Stock
2015-10-06$6.79/sh+2,377→ 41,656 total
Conversion
PDS Biotechnology Corp$PDSB
Common Stock
2015-10-06+21,221→ 36,941 total
Purchase
PDS Biotechnology Corp$PDSB
Common Stock
2015-10-06$11.00/sh+45,000→ 81,941 total
Conversion
PDS Biotechnology Corp$PDSB
Common Stock
2015-10-06+10,443→ 10,443 total
Conversion
PDS Biotechnology Corp$PDSB
Common Stock
2015-10-06+15,720→ 15,720 total
Conversion
PDS Biotechnology Corp$PDSB
Series B-1 Convertible Preferred Stock
2015-10-06−14,286→ 0 total

Companies

Recent Filings

Address

C/O MYOS CORPORATION 45 HORSEHILL ROAD, SUITE 106

CEDAR KNOLLS, NJ, 07927

View on SEC.gov